Sagimet Biosciences director sells 18,844 shares under plan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
George Kemble, a director of Sagimet Biosciences Inc., sold 18,844 shares of Series A Common Stock on July 20, 2026, at a weighted average price of $7.4575 per share in open-market or private transactions under a Rule 10b5-1 trading plan adopted on August 21, 2025. After these sales, he directly holds 62,161 shares. The reported trades occurred at prices ranging from $7.17 to $7.97 per share.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Series A Common Stock F1, F2 | 18,844 | $7.4575 | $141K |
Footnotes (2)
- F1. These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.17 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Series A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Sagimet Biosciences (SGMT) report for director George Kemble?
Was George Kemble’s SGMT stock sale made under a Rule 10b5-1 trading plan?
What type of security did George Kemble sell in Sagimet Biosciences (SGMT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.